SD
Shridhar Diwakar Dhavle
About Shridhar Diwakar Dhavle
Data last updated:
Shridhar Diwakar Dhavle is a Director at Signity Pharmaceuticals Private Limited (since 2010). The company operates in Pharma. Signity Pharmaceuticals Private Limited reported revenue of ₹15.55 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Signity Pharmaceuticals Private Limited U74900MH2010PTC207591 | Director | 13 Sep 2010 | 2010 | ₹15.55 Cr (FY 2025) | Active |
Board colleagues of Shridhar Diwakar Dhavle
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhraman Bhaskar Marliwar | 07784040 | Signity Pharmaceuticals Private Limited | Additional Director |
| Bhupendra Bhaskar Marliwar | 03055079 | Signity Pharmaceuticals Private Limited | Director |
| Bhushan Bhaskar Marliwar | 07775474 | Signity Pharmaceuticals Private Limited | Additional Director |
| Saiye Bhupendra Marliwar | 11025702 | Signity Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shridhar Diwakar Dhavle
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shridhar Diwakar Dhavle
Shridhar Diwakar Dhavle currently holds 1 directorship: Signity Pharmaceuticals Private Limited (Director, since 13 Sep 2010, revenue ₹15.55 Cr (FY 2025)).
Shridhar Diwakar Dhavle was first appointed on 13 Sep 2010 as Director at Signity Pharmaceuticals Private Limited.
The current boards of Shridhar Diwakar Dhavle's companies include Bhraman Bhaskar Marliwar (Signity Pharmaceuticals Private Limited), Bhupendra Bhaskar Marliwar (Signity Pharmaceuticals Private Limited), Bhushan Bhaskar Marliwar (Signity Pharmaceuticals Private Limited), Saiye Bhupendra Marliwar (Signity Pharmaceuticals Private Limited).